A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Santa Monica, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Alexandra Drakaki, MD

Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Alexandra Drakaki, MD
HS Associate Clinical Professor, Medicine. Authored (or co-authored) 116 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Arcus Biosciences, Inc.
- Links
- ARC-20 - Public website Sign up for this study
- ID
- NCT05536141
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 302 study participants
- Last Updated